17β-Estradiol inhibits outward voltage-gated K⁺ currents in human osteoblast-like MG63 cells

Xiantao Li1, Shouchao Zheng, Xuehai Dong

  • 1College of Biomedical Engineering, South-Central University for Nationalities, 708 Minyuan Road, Wuhan 430074, People's Republic of China.

Insights

17β-estradiol inhibits potassium (Kv) channels in human osteoblasts, potentially via Kv2.1 channels. This finding offers insights into hormone action in bone cells.

Area of Science:

  • Molecular Biology
  • Cell Physiology
  • Pharmacology

Background:

  • 17β-estradiol is known to block voltage-gated potassium (Kv) channels in various cell types.
  • Kv currents are present in osteoblasts, but the effect of 17β-estradiol on these currents is not well understood.

Purpose of the Study:

  • To investigate the effects of 17β-estradiol on Kv currents in human osteoblast-like MG63 cells.
  • To elucidate the mechanism of inhibition and identify the molecular Kv channel subtypes involved.

Main Methods:

  • Patch-clamp electrophysiology was used to measure Kv currents in MG63 cells.
  • Kinetic analysis of Kv current activation and inactivation was performed.
  • RT-PCR was employed to identify Kv channel gene expression in MG63 cells.
  • Heterologous expression of Kv2.1 channels in COS-7 cells was used to confirm channel function.

Main Results:

  • 17β-estradiol inhibited peak and sustained Kv currents in MG63 cells with IC₅₀ values of 480 nM and 325 nM, respectively.
  • 17β-estradiol shifted the half-maximum activation potential of Kv currents to more negative potentials.
  • RT-PCR analysis indicated that Kv2.1 channel expression was dominant in MG63 cells.
  • 17β-estradiol inhibited macroscopic currents in COS-7 cells expressing Kv2.1 channels.

Conclusions:

  • 17β-estradiol effectively inhibits Kv currents in human osteoblast-like MG63 cells.
  • Kv2.1 channels are likely a key molecular component responsible for the outward Kv currents in these cells.
  • These findings suggest a potential role for Kv2.1 channels in mediating the effects of 17β-estradiol in osteoblasts.